EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chlorogenic Acid Attenuates Doxorubicin-Induced Oxidative Stress and Markers of Apoptosis in Cardiomyocytes via Nrf2/HO-1 and Dityrosine Signaling

Betul Cicek, Ahmet Hacimuftuoglu, Yesim Yeni iD, Betul Danisman, Mustafa Ozkaraca iD, Behzad Mokhtare, Mecit Kantarci, Marios Spanakis iD, Dragana Nikitovic iD, Georgios Lazopoulos, Konstantinos Tsarouhas iD, Aristidis Tsatsakis iD und 1 weitere

Journal of Personalized Medicine · 10.04.2023 · 13 (4) · 649

DOI: 10.3390/jpm13040649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.04.2023. Verfasst von Betul Cicek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, 24100 Erzincan, Turkey. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Doxorubicin (DOX) is extensively used for cancer treatments; however, its clinical application is limited because of its cardiotoxic adverse effects. A combination of DOX and agents with cardioprotective properties is an effective strategy to ameliorate DOX-related cardiotoxicity. Polyphenolic compounds are ideal for the investigation of novel cardioprotective agents. Chlorogenic acid (CGA), an essential dietary polyphenol found in plants, has been previously reported to exert antioxidant, cardioprotective, and antiapoptotic properties. The current research evaluated CGA’s in vivo cardioprotective properties in DOX-induced cardiotoxicity and the probable mechanisms underlying this protection. (2)

Methods

CGA’s cardioprotective properties were investigated in rats that were treated with CGA (100 mg/kg, p.o.) for fourteen days. The experimental model of cardiotoxicity was induced with a single intraperitoneal (15 mg/kg i.p.) injection of DOX on the 10th day. (3)

Results

Treatment with CGA significantly improved the DOX-caused altered cardiac damage markers (LDH, CK-MB, and cTn-T), and a marked improvement in cardiac histopathological features accompanied this. DOX downregulated the expression of Nrf2/HO-1 signaling pathways, and the CGA reversed this effect. Consistently, caspase-3, an apoptotic-related marker, and dityrosine expression were suppressed, while Nrf2 and HO-1 expressions were elevated in the cardiac tissues of DOX-treated rats after treatment with the CGA. Furthermore, the recovery was confirmed by the downregulation of 8-OHdG and dityrosine (DT) expressions in immunohistochemical findings. (4)

Conclusions

CGA demonstrated a considerable cardioprotective effect against DOX-induced cardiotoxicity. One of the possible mechanisms for these protective properties was the upregulation of the Nrf2/HO-1-dependent pathway and the downregulation of DT, which may ameliorate oxidative stress and cardiomyocyte apoptosis. These findings suggest that CGA may be cardioprotective, particularly in patients receiving DOX-based chemotherapy.

Schlagwörter

Stichwörter der Autor:innen

Nrf2/HO-1cardiotoxicitychlorogenic aciddoxorubicinoxidative stress

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, 24100 Erzincan, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, Ataturk University, 25240 Erzurum, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Turkey.
  • Department of Biophysics, Faculty of Medicine, Ataturk University, 25240 Erzurum, Turkey.
  • Department of Pathology, Faculty of Veterinary, Sivas Cumhuriyet University, 58140 Sivas, Turkey.
  • Department of Radiology, Faculty of Medicine, Ataturk University, 25240 Erzurum, Turkey.

ORCID-Profile: Yesim Yeni, Mustafa Ozkaraca, Marios Spanakis, Dragana Nikitovic, Konstantinos Tsarouhas, Aristidis Tsatsakis, Ali Taghizadehghalehjoughi

Zitieren

APA

Cicek, B., Hacimuftuoglu, A., Yeni, Y., Danisman, B., Ozkaraca, M., Mokhtare, B., Kantarci, M., Spanakis, M., Nikitovic, D., Lazopoulos, G., Tsarouhas, K., Tsatsakis, A., & Taghizadehghalehjoughi, A. (2023). Chlorogenic Acid Attenuates Doxorubicin-Induced Oxidative Stress and Markers of Apoptosis in Cardiomyocytes via Nrf2/HO-1 and Dityrosine Signaling. Journal of Personalized Medicine, 13(4), 649. https://doi.org/10.3390/jpm13040649

Vancouver

Cicek B, Hacimuftuoglu A, Yeni Y, Danisman B, Ozkaraca M, Mokhtare B, et al. Chlorogenic Acid Attenuates Doxorubicin-Induced Oxidative Stress and Markers of Apoptosis in Cardiomyocytes via Nrf2/HO-1 and Dityrosine Signaling. Journal of Personalized Medicine. 2023;13(4):649. doi:10.3390/jpm13040649

BibTeX
@article{Cicek2023,
  author = {Cicek, Betul and Hacimuftuoglu, Ahmet and Yeni, Yesim and Danisman, Betul and Ozkaraca, Mustafa and Mokhtare, Behzad and Kantarci, Mecit and Spanakis, Marios and Nikitovic, Dragana and Lazopoulos, Georgios and Tsarouhas, Konstantinos and Tsatsakis, Aristidis and Taghizadehghalehjoughi, Ali},
  title = {Chlorogenic Acid Attenuates Doxorubicin-Induced Oxidative Stress and Markers of Apoptosis in Cardiomyocytes via Nrf2/HO-1 and Dityrosine Signaling},
  journal = {Journal of Personalized Medicine},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {649},
  doi = {10.3390/jpm13040649}
}
Kostenlos starten →